Aetna Inc (AET) 111.17 $AET 3 Managed Health Care Stocks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aetna Inc (AET) 111.17 $AET

3 Managed Health Care Stocks to Buy
at The Street - Tue Jul 28, 8:02AM CDT
With Anthem agreeing to acquire Cigna for $48 billion, we decided to check Quant Ratings to see if there are any good stocks in that sub-industry, worth buying.
CI: 145.93 (+0.03), ANTM: 153.96 (+2.46), UNH: 121.05 (+3.17), AET: 111.17 (+0.94)

3 Reasons Why Earnings Season is Going Great
at The Street - Mon Jul 27, 10:00AM CDT
Strong quarterly results show that the market is more bearish than it should be right now.
AMZN: 526.62 (-4.79), HD: 114.80 (+1.73), AET: 111.17 (+0.94), HUM: 184.30 (+0.39), SBUX: 57.05 (+0.07), CI: 145.93 (+0.03), UA: 97.44 (+1.01), ANTM: 153.96 (+2.46), MCD: 97.28 (+1.24), GOOGL: 660.85 (+2.58), CAT: 77.87 (+2.55), AAPL: 123.73 (+0.96)

Anthem to Buy Cigna: IHF ETF On Fire, Others in Focus - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Jul 27, 9:25AM CDT
The proposed takeover of Cigna by Anthem has put these ETFs in focus.
CI: 145.93 (+0.03), IHF: 138.40 (+1.04), ANTM: 153.96 (+2.46), DVP: 23.12 (+0.25), RWV: 50.59 (+0.23), UNH: 121.05 (+3.17), AET: 111.17 (+0.94), HUM: 184.30 (+0.39)


Israel's Teva buys Allergan generic drug company for $40.5B
By DANIEL ESTRIN - AP - Mon Jul 27, 1:14PM CDT
JERUSALEM (AP) — Israel's Teva Pharmaceutical Industries Ltd. said Monday it is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion, in what Israeli analysts called the largest-ever acquisition by an Israeli company.
CI: 145.93 (+0.03), AGN: 337.50 (+10.52), ANTM: 153.96 (+2.46), ANTX: 50.67 (+0.39), MYL: 55.72 (-0.65), TEVA: 71.12 (-0.88), AET: 111.17 (+0.94), HUM: 184.30 (+0.39)

Do 3 big insurers flash red for govt? Mergers get close look
By MARCY GORDON - AP - Fri Jul 24, 7:17PM CDT
WASHINGTON (AP) — Would a reduction from five health insurance giants to three trigger a flashing light for regulators concerned about industry competition?
CI: 145.93 (+0.03), AET: 111.17 (+0.94), HUM: 184.30 (+0.39)

Business Highlights
By The Associated Press - AP - Fri Jul 24, 5:24PM CDT
___
CI: 145.93 (+0.03), AMZN: 526.62 (-4.79), UNH: 121.05 (+3.17), WMT: 72.25 (+0.87), JBLU: 22.90 (+0.55), CMCSK: 62.01 (+1.08), BMY: 64.51 (+0.21), CMCSA: 62.22 (+1.11), AET: 111.17 (+0.94), REGN: 556.30 (+16.27), HUM: 184.30 (+0.39)

Why the 2010 health care law led to insurance merger mania
AP - Fri Jul 24, 2:40PM CDT
NEW YORK (AP) — The health care overhaul law has reshaped the health insurance business, and one consequence is more than $100 billion in mergers and acquisitions over the last few years.
CI: 145.93 (+0.03), ANTM: 153.96 (+2.46), UNH: 121.05 (+3.17), ANTX: 50.67 (+0.39), AET: 111.17 (+0.94), HUM: 184.30 (+0.39)

Anthem Acquires Cigna in $54 Billion Insurance Merger: 7 Key Takeaways - Stocks in the News
Madeleine Johnson - Zacks Investment Research - Fri Jul 24, 1:08PM CDT
Announced Friday, health care company Anthem Inc will buy fellow insurer Cigna Corp in a deal that reaches $54 billion. Here’s a look at what investors should know about the latest high-profile insurance acquisition.
CI: 145.93 (+0.03), ANTM: 153.96 (+2.46), AET: 111.17 (+0.94), HUM: 184.30 (+0.39)


Mega-health deals bloom in July, Anthem bids $48B for Cigna
By TOM MURPHY and MICHELLE CHAPMAN and MATTHEW PERRONE - AP - Fri Jul 24, 12:58PM CDT
NEW YORK (AP) — Anthem is buying rival Cigna for $48 billion in a deal that would create the nation's largest health insurer by enrollment, covering about 53 million U.S patients.
CI: 145.93 (+0.03), ANTM: 153.96 (+2.46), ANTX: 50.67 (+0.39), UNH: 121.05 (+3.17), AET: 111.17 (+0.94), HUM: 184.30 (+0.39)

Glance: The new 'Big Three' of health coverage
By The Associated Press - AP - Fri Jul 24, 12:34PM CDT
Anthem Inc.'s $48 billion purchase of rival Cigna Corp. is set to create the nation's largest health insurance company.
CI: 145.93 (+0.03), ANTM: 153.96 (+2.46), ANTX: 50.67 (+0.39), AET: 111.17 (+0.94), HUM: 184.30 (+0.39)

Anthem To Buy Cigna As Insurers Rush To Consolidate
at Investor's Business Daily - Fri Jul 24, 7:34AM CDT
Anthem (ANTM) confirmed Friday that it will buy Cigna (CI) for $48 billion, as the health care industry continues its recent consolidation. Anthem will pay $188 a share, with Cigna shareholders receiving $103.40 in cash and 0.5152 Anthem shares for...
CNC: 69.35 (+0.25), CI: 145.93 (+0.03), ANTM: 153.96 (+2.46), UNH: 121.05 (+3.17), AET: 111.17 (+0.94), HNT: 65.94 (+0.34), HUM: 184.30 (+0.39)

HMOs Burn Hot This Summer - Video Blog
John Blank - Zacks Investment Research - Thu Jul 23, 12:09PM CDT
What's Heating Up the HMO Industry?
ANTM: 153.96 (+2.46), AET: 111.17 (+0.94)

Anthem Set to Acquire Cigna for $48 Billion - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Thu Jul 23, 11:51AM CDT
Health insurance giant Anthem (ANTM) is gearing up for an acquisition of competitor Cigna (CI), reports say.
CI: 145.93 (+0.03), ANTM: 153.96 (+2.46), AET: 111.17 (+0.94), HUM: 184.30 (+0.39)

And Then There Were 3? Anthem Near $48 Bil Cigna Deal
at Investor's Business Daily - Wed Jul 22, 10:27PM CDT
Anthem (ANTM) will announce a deal to buy Cigna (CI) for about $48 billion, or $187 a share as soon as Thursday, according to a variety of reports. Along with other mergers, the managed care industry on the road to shrinking to three giants from five...
CNC: 69.35 (+0.25), CI: 145.93 (+0.03), ANTM: 153.96 (+2.46), UNH: 121.05 (+3.17), AET: 111.17 (+0.94), HNT: 65.94 (+0.34), HUM: 184.30 (+0.39)

Molina Scoffs At Merger Mania, Keeps Growing Medicaid
at Investor's Business Daily - Wed Jul 22, 12:58PM CDT
As consolidation fever grips the managed care industry, Molina Healthcare (MOH) prefers to "stick to our knitting," as chief financial officer John Molina likes to say. Its knitting since its founding in 1980 by Molina's father, David Molina, has...
CNC: 69.35 (+0.25), ANTM: 153.96 (+2.46), UNH: 121.05 (+3.17), WCG: 78.57 (+0.46), AET: 111.17 (+0.94), HNT: 65.94 (+0.34), MOH: 68.23 (-0.19), HUM: 184.30 (+0.39)

Industry Snapshot: Dig Deep Into Hottest Industries
at Investor's Business Daily - Tue Jul 21, 6:05PM CDT
Context means a lot when you're trying to understand just what a company does and identify its strengths. And context, in the business world, means industry. As you study a company and try to determine if it's going to be a profit gusher, ask these...
CI: 145.93 (+0.03), ANTM: 153.96 (+2.46), CMG: 729.83 (-1.61), MCD: 97.28 (+1.24), AET: 111.17 (+0.94)

After Yesterday's Decline of 1.17%, Aetna Offers Investors Better Value
Comtex SmarTrend(R) - Mon Jul 20, 4:15PM CDT
Aetna (NYSE:AET) traded in a range yesterday that spanned from a low of $111.04 to a high of $113.14. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $111.26 on volume of 2.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AET: 111.17 (+0.94)

Look for Shares of Aetna to Potentially Rebound after Yesterday's 1.17% Sell Off
Comtex SmarTrend(R) - Mon Jul 20, 4:14PM CDT
Aetna (NYSE:AET) traded in a range yesterday that spanned from a low of $111.04 to a high of $113.14. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $111.26 on volume of 2.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AET: 111.17 (+0.94)

Humana Faces Operational Risks, Agrees to Merge with Aetna - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 20, 3:15PM CDT
On Jul 17, 2015, we issued an updated research report on Humana (HUM).
ANTM: 153.96 (+2.46), SEM: 14.90 (+0.10), AET: 111.17 (+0.94), HUM: 184.30 (+0.39)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 544

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 109

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 411

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 174

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Roche Unveils High-Sensitivity Troponin T Test Increasing Diagnosis Precision

Updated Category News Views 350

The Unveiling of Roche's Sixth-Generation Troponin T Test Roche has recently been granted a CE Mark for its innovative sixth-generation Troponin T test, which promises to deliver a new level of accuracy that is critical for diagnosing heart attacks. This novel testing solution is designed to enhance sensitivity and precision, allowing for quicker and more reliable...

Continue Reading
Maximize Your Earnings with Keurig Dr Pepper Stock Strategy

Updated Category News Views 133

Understanding Keurig Dr Pepper's Earnings Potential Keurig Dr Pepper Inc. (NASDAQ: KDP) is preparing to share its third quarter earnings results shortly. Investors eagerly await the disclosures, which are expected to highlight positive financial trends and growth. Analysts predict that the company will report earnings per share of 54 cents, an increase from 51 cents in...

Continue Reading
Uwharrie Capital Corp Celebrates Year-End Financial Growth

Updated Category News Views 113

Uwharrie Capital Corp Reports Strong Year-End Results Uwharrie Capital Corp and its subsidiary, Uwharrie Bank, have recently unveiled impressive financial results that reflect their continued strength and stability in the banking sector. The company reported consolidated total assets of $1.13 billion at the end of the reporting period, demonstrating a noticeable increase...

Continue Reading
Enhancing California's Tourism Appeal with Interactive Design

Updated Category News Views 148

Revolutionizing Tourism Through Interactive Web Design In today's fast-paced digital world, engaging younger travellers has become crucial for tourism boards in California. Digital Silk, an award-winning agency renowned for its expertise in digital marketing and web design, is leading the charge to inspire Generation Z and millennials by advocating for the adoption of...

Continue Reading
FOX News Digital Dominates October with Record-Breaking View Counts

Updated Category News Views 174

FOX News Digital Achieves Historic Success in October Leading YouTube with 377 Million Video Views During the month of October, FOX News Digital achieved outstanding milestones, topping the charts in multiplatform engagement. With a staggering 3.7 billion multiplatform minutes and 1.8 billion views, the platform outshined its competitors, establishing its dominance in the...

Continue Reading